Results represent that the DNAJC10 expression is significantly associated with the clinicopathological features of gliomas like WHO grade, isocitrate dehydrogenase (IDH) mutation status, 1p/19q co-deletion status, and O(6)-methylguanine-DNA methyltransferase (MGMT) methylation status. Here, IDH3A is linked to central nervous system cancer.